Peripheral veno-arterial extracorporeal membrane oxygenation during lung transplantation with special reference to differential hypoxemia and vascular complications
Norihisa Shigemura,Hiromu Kehara,Yoshiya Toyoda
DOI: https://doi.org/10.21037/jtd-23-1630
2024-02-01
Journal of Thoracic Disease
Abstract:Norihisa Shigemura, Hiromu Kehara, Yoshiya Toyoda Division of Cardiovascular Surgery, Lewis Katz School of Medicine, Temple University Health System, Philadelphia, PA, USA Keywords: Lung transplantation; peripheral arterial disease (PAD); computed tomography scans of the abdomen and pelvis (CTAP); extracorporeal membrane oxygenation (ECMO); abdominal aortic aneurysm (AAA) Submitted Oct 25, 2023. Accepted for publication Dec 19, 2023. Published online Jan 09, 2024. doi: 10.21037/jtd-23-1630 In clinical lung transplantation, the role of intraoperative mechanical circulatory support (MCS) cannot be overemphasized, as it impacts transplant outcomes in multiple ways. Although it is difficult to conclude which MCS options are optimal without a randomized controlled trial with an intention-to-treat breakdown, robust data strongly support veno-arterial extracorporeal membrane oxygenation (VA ECMO) for MCS during lung transplantation (1,2). As proponents of liberal VA ECMO use during lung transplant procedures at a high-volume transplant center, we believe that this option contributes to optimal allograft protection during the procedure and ultimately leads to improved posttransplant outcomes. The potential benefits of peripheral VA ECMO have been understated, and its potential pitfalls, which include differential hypoxemia and ECMO cannulation-associated peripheral vascular complications, have not been duly discussed. In this review, we detail our latest insights on the peripheral VA ECMO approach. Through presentation of our original data, we also highlight the solid strategy of using a peripheral VA ECMO approach for MCS combined with minimally invasive, antero-lateral thoracotomy surgical approach for lung transplant. This strategy is particularly useful for high-risk or elderly patients in light of the unique challenges and limitations associated with geriatric lung transplantation. Increasing evidence has demonstrated that VA ECMO is a superior modality to full cardiopulmonary bypass for intraoperative MCS during lung transplant procedures (3,4). Cannulation for VA ECMO can be performed centrally or peripherally. Central cannulation, which enables better blood drainage and avoids peripheral cannulation-related complications, has been preferred; however, bleeding complications from central cannulation sites are not negligible. In addition, in patients with suppurative lung diseases with extensive pleural and mediastinal involvement, such as complex cystic fibrosis, central cannulation should be avoided due to concerns that contamination of the cannulation sites and circuits may precipitate bacteremia or microaneurysm in immunosuppressed patients. In contrast, peripheral cannulation through the common femoral artery and femoral vein, separate and apart from chest exploration, can alleviate such concerns. Additionally, it may help surgeons focus on challenges in the chest with exposure that is not disturbed by cannulas or cannulation-associated complications, in particular when antero-lateral thoracotomy approach is routinely used for minimally invasive transplant as it is at our center, as these are safely established in the groin in a separate manner. Preoperative computed tomography (CT) assessment plays a key role in preventing peripheral vascular complications and determining optimal MCS approach during lung transplantation The use of peripheral arterial access through groin for VA ECMO is increasing due in part to the recent advent of minimally invasive cardiac surgical interventions. In 2017, based on our extensive experience caring for older patients with end-stage lung disease who are often found to have concurrent peripheral arterial disease (PAD), we implemented a pretransplant assessment of PAD with CT scans of the abdomen and pelvis (CTAP) for all lung transplant candidates over 65 years of age and for younger candidates with outstanding cardiovascular or metabolic comorbidities. Our CTAP assessment for PAD utilizes a semi-quantitative 5-point scale to classify vascular calcifications over the distal aorta, common iliac artery, external iliac artery, and common femoral arteries, ranging from absent or minimal calcifications to severe diffuse calcification using criteria established previously (5). Then, we stratified the patients into two groups based on the vascular calcification scores: low calcification (score 1–2) and high calcification (score 3–5). Additionally, patients who had an abdominal aortic aneurysm (AAA) or an iliac artery aneurysm (IAA) were identified using the same CT images. AAA and IAA were defined as vessels with a maximal diameter of >30 mm for AAA and >20 mm for IAA in axial CT image slices. When PAD was quantified in 130 lung transplant patients over 70 years of age who underwent lung transplantation at our center between January 2018 and December 2020, 44% of the patients (57/130) had high vascular calci -Abstract Truncated-
respiratory system